The coronavirus vaccine made nine children so ill that they are now receiving millions in compensation.

When the Danish Health Authority in 2021 recommended that parents have their children vaccinated against COVID-19, the primary aim was to curb chains of infection in society, avoid overloading hospitals, and protect grandparents (https://www.dr.dk/nyheder/indland/sundhedsstyrelsen-anbefaler-vaccination-af-boern-mellem-5-og-11-aar).

Consequently, more than half a million children between the ages of 5 and 17 rolled up their sleeves and got vaccinated against the virus in 2021 and 2022.

> The purpose of offering vaccination to children was to help gain control of the epidemic

> Danish Health Authority

At that time, COVID-19 dominated most of the news coverage and was also one of the most discussed and controversial topics in the country.

But for nine Danes, who were between 5 and 17 years old when they received the shot, the vaccine had such a serious downside that they have now been awarded millions in compensation for side effects.

This is shown by a report from the Patient Compensation Association, prepared for Berlingske (https://www.berlingske.dk/indland/boern-fik-alvorlige-skader-efter-covid-19-vaccine-nu-faar-de-millionerstatning), which DR also has access to.

"Our task is to try to bring closure to the patients' cases. But we also know that compensation unfortunately does not remove the injury they have to live with," says Karen-Inger Bast, director of the Patient Compensation Association, to Berlingske and DR.

Read also: Sweden does not recommend vaccination for children aged 5 to 11 (https://www.dr.dk/nyheder/seneste/sverige-anbefaler-ikke-vaccination-til-boern-mellem-5-og-11-aar)

The side effects that the nine individuals have suffered are chronic hives, inflammation of the heart lining and heart muscle, an inflammatory condition of the central nervous system, and encephalitis.

In total, the nine individuals have been awarded 3,184,801 kroner in compensation.

----------------------------------------------------

Nine individuals awarded compensation after corona vaccine

----------------------------------------------------

9 people who were under 18 when they were vaccinated against COVID-19 have received compensation for the side effects they suffered from the vaccine.

This is a very small proportion of the many thousands of children who received the vaccine.

During 2021 and 2022, more than half a million children aged 5 to 17 received at least one vaccine dose.

For those aged 5 to 11, this applied to 210,095, while for those aged 12 to 15 it applied to 247,225.

We do not have exact figures for those aged 16-17.

In total, there are 78 cases concerning children who received a COVID-19 vaccine and have applied for compensation for side effects. Of these, 9 have received compensation, while 67 have been rejected. One case has not yet been decided, according to figures from the Patient Compensation Association.

Sources: Danish Health Authority and Patient Compensation Association

-------------------------------------------------------------

Danish Health Authority: 'The purpose was to gain control of the epidemic'

-------------------------------------------------------------

According to the Patient Compensation Association, the high compensation amount should be seen in light of the Damages Liability Act.

This gives children under 15 the right to so-called loss of earning capacity compensation corresponding to their permanent impairment, and this applies even if the permanent impairment may never affect the child's ability to hold a job.

The Danish Health Authority, which was behind the vaccine recommendations, writes to DR that they are not aware of the specific cases, but that they view side effects "with great seriousness."

"The purpose of offering vaccination to children was to help gain control of the epidemic and to prevent serious illness and death in the population, especially among the oldest and most vulnerable people," it states, among other things.

The authority also states that it continuously assesses whether existing and new vaccination offers should be introduced or phased out of the national vaccination program.

Warning: This article was translated by a Large Language Model, in case of doubt, you can always visit the original source.